NASDAQ: OCUPOcuphire Pharma Inc Stock Ownership - Who owns Ocuphire Pharma?
Insider buying vs selling
Have Ocuphire Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Nirav S. Jhaveri | Chief Financial Officer | 2024-03-21 | 10,000 | $2.10 | $21.00kBuy |
| Joseph K. Schachle | Chief Operating Officer | 2024-03-21 | 2,000 | $2.05 | $4.10kBuy |
| George Magrath | Chief Executive Officer | 2024-03-18 | 25,000 | $1.96 | $49.05kBuy |
| Bernhard Hoffmann | SVP of Corp. Dev. | 2024-01-10 | 4,031 | $3.27 | $13.16kSell |
| Ronil A. Patel | Chief Business Officer | 2024-01-10 | 1,282 | $3.27 | $4.19kSell |
| Rabourn Amy Zaremba | SVP of Finance | 2024-01-10 | 3,950 | $3.27 | $12.90kSell |
OCUP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OCUP insiders and whales buy or sell their stock.
OCUP Shareholders
What type of owners hold Ocuphire Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sungkee Chung | 660.13% | 163,800,000 | $252.25M | Insider |
| Sung Sook Park | 282.91% | 70,200,000 | $108.11M | Insider |
| Frank Ferraro | 104.78% | 26,000,000 | $40.04M | Insider |
| Inok Ahn | 56.42% | 14,000,000 | $21.56M | Insider |
| Chang Ho Ahn | 46.39% | 11,510,000 | $17.73M | Insider |
| Rexgene Biotech Co Ltd | 22.19% | 5,505,956 | $8.48M | Insider |
| Young Soon Park | 10.91% | 2,706,500 | $4.17M | Insider |
| Vanguard Group Inc | 3.74% | 927,800 | $1.43M | Institution |
| Rice Hall James Associates LLC | 2.30% | 571,777 | $880.54k | Institution |
| Mina Sooch | 2.14% | 530,501 | $816.97k | Insider |
OCUP vs Biotech Stocks
Ocuphire Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.